181 related articles for article (PubMed ID: 34291109)
1. Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β
Thomassen JC; Trojan T; Walz M; Vohlen C; Fink G; Rietschel E; Alejandre Alcazar MA; van Koningsbruggen-Rietschel S
ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34291109
[TBL] [Abstract][Full Text] [Related]
2. The effect of TGF-β
Trojan T; Alejandre Alcazar MA; Fink G; Thomassen JC; Maessenhausen MV; Rietschel E; Schneider PM; van Koningsbruggen-Rietschel S
BMC Pulm Med; 2022 May; 22(1):183. PubMed ID: 35525938
[TBL] [Abstract][Full Text] [Related]
3. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
4. Sputum and Plasma Neutrophil Elastase in Stable Adult Patients With Cystic Fibrosis in Relation to Chronic Pseudomonas Aeruginosa Colonization.
AbdulWahab A; Allangawi M; Thomas M; Bettahi I; Sivaraman SK; Jerobin J; Chandra P; Ramanjaneya M; Abou-Samra AB
Cureus; 2021 Jun; 13(6):e15948. PubMed ID: 34221778
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
[TBL] [Abstract][Full Text] [Related]
6. Anti-protease levels in cystic fibrosis are associated with lung function, recovery from pulmonary exacerbations and may be gender-related.
Essilfie AT; Houston N; Maniam P; Hartel G; Okano S; Reid DW
Respirology; 2023 Jun; 28(6):533-542. PubMed ID: 36642534
[TBL] [Abstract][Full Text] [Related]
7. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG
Front Immunol; 2022; 13():947359. PubMed ID: 36466839
[TBL] [Abstract][Full Text] [Related]
8. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.
Milla CE; Chmiel JF; Accurso FJ; VanDevanter DR; Konstan MW; Yarranton G; Geller DE;
Pediatr Pulmonol; 2014 Jul; 49(7):650-8. PubMed ID: 24019259
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
10. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.
Dittrich AS; Kühbandner I; Gehrig S; Rickert-Zacharias V; Twigg M; Wege S; Taggart CC; Herth F; Schultz C; Mall MA
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545279
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.
Oriano M; Terranova L; Sotgiu G; Saderi L; Bellofiore A; Retucci M; Marotta C; Gramegna A; Miglietta D; Carnini C; Marchisio P; Chalmers JD; Aliberti S; Blasi F
Pulm Pharmacol Ther; 2019 Dec; 59():101856. PubMed ID: 31626976
[TBL] [Abstract][Full Text] [Related]
12. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.
Sagel SD; Wagner BD; Anthony MM; Emmett P; Zemanick ET
Am J Respir Crit Care Med; 2012 Nov; 186(9):857-65. PubMed ID: 22904182
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC.
Taylor PR; Bonfield TL; Chmiel JF; Pearlman E
Clin Immunol; 2016 Sep; 170():53-60. PubMed ID: 27155366
[TBL] [Abstract][Full Text] [Related]
14. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
[TBL] [Abstract][Full Text] [Related]
15. KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa.
Jain R; Beckett VV; Konstan MW; Accurso FJ; Burns JL; Mayer-Hamblett N; Milla C; VanDevanter DR; Chmiel JF;
J Cyst Fibros; 2018 Jul; 17(4):484-491. PubMed ID: 29292092
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 levels in children with cystic fibrosis.
Ademhan Tural D; Emiralioglu N; Akin S; Alboga D; Ozsezen B; Nayir Buyuksahin H; Guzelkas I; Kasikci M; Sunman B; Gungor I; Yalcin E; Dogru D; Kiper N; Demirel AH; Ozcelik U
Eur J Pediatr; 2024 May; 183(5):2333-2342. PubMed ID: 38430280
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.
Jones AM; Martin L; Bright-Thomas RJ; Dodd ME; McDowell A; Moffitt KL; Elborn JS; Webb AK
Eur Respir J; 2003 Sep; 22(3):503-6. PubMed ID: 14516142
[TBL] [Abstract][Full Text] [Related]
18. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
[TBL] [Abstract][Full Text] [Related]
19. A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation.
Chillappagari S; Müller C; Mahavadi P; Guenther A; Nährlich L; Rosenblum J; Rubin BK; Henke MO
J Cyst Fibros; 2016 May; 15(3):325-31. PubMed ID: 26526358
[TBL] [Abstract][Full Text] [Related]
20. Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition.
Keir HR; Fong CJ; Crichton ML; Barth P; Chevalier E; Brady G; Kennedy G; Zimmermann J; Bruijnzeel PLB; Dicker AJ; Chalmers JD
ERJ Open Res; 2019 Feb; 5(1):. PubMed ID: 30918898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
